Context Therapeutics Inc. - CNTX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 17
Latest filed: Apr 02, 2026
| Form | Count |
|---|---|
| 8-K | 8 |
| 4 | 4 |
| SCHEDULE 13G/A | 4 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 02, 2026 | 8-K | Apr 02, 2026 | 0001628280-26-022931 | View |
| Mar 23, 2026 | 8-K | Mar 23, 2026 | 0001628280-26-020517 | View |
| Mar 13, 2026 | 8-K | Mar 11, 2026 | 0001628280-26-017691 | View |
| Feb 27, 2026 | 8-K | Feb 24, 2026 | 0001628280-26-012813 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010616 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010637 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010642 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010660 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001687078-26-000005 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001172661-26-001118 | View |
| Feb 03, 2026 | SCHEDULE 13G | — | 0001213900-26-011516 | View |
| Jan 08, 2026 | 8-K | Jan 08, 2026 | 0001628280-26-001275 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0001814554-25-000171 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0000919574-25-007016 | View |
| Nov 05, 2025 | 8-K | Nov 05, 2025 | 0001628280-25-049604 | View |
| Oct 24, 2025 | 8-K | Oct 24, 2025 | 0001628280-25-046258 | View |
| Oct 20, 2025 | 8-K | Oct 17, 2025 | 0001628280-25-045513 | View |